Atlas Trials

Tasquinimod for the Treatment of Relapsed or Refractory Myeloma

Clinical trial NCT04405167 · TERMINATED

Trial details

NCT number
NCT04405167
Sponsor
University of Pennsylvania
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2020-07-10
Primary completion
2025-05-19
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.